TOUYUN BIOTECH (01332.HK): Luo Dan appointed executive director and chairman, Wang Liang moves to vice chairman

On 20 November 2026, Touyun Biotech (01332.HK) said Luo Dan was appointed executive director and chairman, Wang Liang was re-designated from chairman to vice chairman with his monthly salary cut from HK$300,000 to HK$200,000, and Zhang Lele resigned as a non-executive director.

NewTimeSpace News: On 20 November 2026, Touyun Biotech Group Limited (01332.HK) announced several board changes, all effective from 20 November 2026. Mr. Luo Dan has been appointed an executive director and the chairman of the board. Aged 41, he holds a Master of Business Administration from Fudan University and is currently general manager of Shanghe International Investment Group Co., Ltd. He has extensive cross-border capital markets investment experience, having worked at well-known PRC private equity funds and public funds, with focus areas spanning consumer and cultural tourism, healthcare and elderly care, bio-agriculture, and energy and computing power, and in 2013 initiated and managed China's first talent fund. Mr. Luo has entered into a three-year service contract with the Company, terminable by either party on one month's written notice, and his appointment is subject to retirement by rotation and re-election at the next annual general meeting. He is entitled to a director's fee of HK$300,000 per month.

Mr. Wang Liang has been re-designated from chairman to vice chairman of the board and remains an executive director, serving alongside the existing vice chairman, Ms. Zhou Ruijuan. His monthly salary has been adjusted from HK$300,000 to HK$200,000, as determined by the board with reference to the duties and responsibilities of his new position. Mr. Wang holds a Bachelor of Science in Physics from Imperial College London and a Master's degree in International Finance from the University of Westminster, and has extensive experience in international financing and project management. He joined the Group in December 2012, was appointed an executive director on 1 September 2016 and has served as chairman since 23 January 2017.

Mr. Zhang Lele has resigned as a non-executive director due to personal commitments and remains a vice president of a subsidiary of the Company, effective the same day. Mr. Zhang has confirmed that he has no disagreement with the board and that there are no matters relating to his resignation that need to be brought to the attention of shareholders or The Stock Exchange of Hong Kong Limited. The board expressed its sincere appreciation to Mr. Zhang for his valuable contributions during his tenure and welcomed Mr. Luo to the board.

×
Share to WeChat

Open WeChat, use the "Scan", and share to my Moments.